Accipiterbio
accipiterbio.com
Biotechnology
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$24.7M
3 rounds on record
Latest round
$10.5M
Venture round · Jul 2026 · 3 mo ago
Team
51-200
employees, estimated range
The money's age
Fresh money
3 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 21
Raised a round Venture round $10.5M · SEC Form D
May 17, 2024
Raised a round Venture round $13.6M · SEC Form D
Apr 19, 2023
Raised a round Convertible Note $650k · SEC Form D
2023
Founded
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2026 | $10.5M | — | SEC Form D |
| Venture round | May 2024 | $13.6M | — | SEC Form D |
| Convertible Note | Apr 2023 | $650k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Accipiter Biosciences Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Matthew BickExecutive Officer, DirectorSEC Form D
Hector De Jesus Rincon AranoExecutive Officer, DirectorSEC Form D
Javier CastellanosExecutive Officer, DirectorSEC Form D
William CanestaroExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
backs BioGeometry
Similar startupsby what they do, their industry and backers
Monod Bio launched in 2022 as a spin-out from the Baker Lab. Since then, we have been using AI-powered de novo protein design to create RUO…
Home. Developing therapies to dynamically control gene expression and treat complex disease.
Numen is a biotechnology startup developing rapid at-home diagnostic tests intended to detect cancer early and reduce cancer deaths. Its…
BioGeometry is a digital biology pioneer that specializes in applying generative AI to protein design.
Our breakthrough protein design platform transforms our clients’ visions into reality.
Human-enabled Machine-driven. De novo designed mini-proteins and single domain antibodies to help drug hunters deliver life-saving…
People
Matthew Bick
Executive Officer, Director
Hector De Jesus Rincon Arano
Executive Officer, Director
Javier Castellanos
Executive Officer, Director
William Canestaro
Executive Officer
Heather Redman
Director
Randall Schatzman
Director
Jose Antonio Mesa Cejudo
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Seattle
United States
HQ
50-200 est. staff